万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>SCI/SCIE期刊 >>医药卫生>>药物学

AAPS PharmSciTech(研究方向:药学) (官网投稿)

简介
AAPS PharmSciTech(双月刊),创刊于2000年,出版国家为美国。AAPS PharmSciTech是一本经过同行评审的在线专刊,致力于为那些对药物剂型和递送系统的研究,开发和评估感兴趣的药物科学家和工程师提供服务,包括生物技术衍生的药物和与商业化有关的制造科学的这种剂型。由于其电子性质,AAPS PharmSciTech渴望利用不断发展的电子技术,使其更快更多样化的信息传递到读者群体中。欢迎...[显示全部]
本刊为:SCIE期刊(2015-2016), 外文期刊,
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://www.aapspharmscitech.org/

3、期刊投稿:

http://www.editorialmanager.com/aapspt/

4、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017426日星期三

                    

 

Author Guidelines

 

Aims and Scope

 

AAPS PharmSciTech is a peer-reviewed, online-only journal committed to serving those pharmaceutical scientists and engineers interested in the research, development, and evaluation of pharmaceutical dosage forms and delivery systems, including drugs derived from biotechnology and the manufacturing science pertaining to the commercialization of such dosage forms. Because of its electronic nature, AAPS PharmSciTech aspires to utilize evolving electronic technology to enable faster and diverse mechanisms of information delivery to its readership. Submission of uninvited expert reviews and research articles are welcomed.

 

AAPS PharmSciTech publishes six issues a year.

 

TYPES OF MANUSCRIPTS

AAPS PharmSciTech publishes the following article types. For examples of published articles, please visit www.PharmaGateway.net.

Reviews, usually by invitation and sometimes organized into theme issues, report on recent advances in pharmaceutical research. Unsolicited reviews are considered only if they are authored by investigators who have demonstrated expertise in the relevant areas.

Mini-reviews discuss a more narrowly focused topic of recent research. Unsolicited mini-reviews are considered only if they are authored by investigators who have demonstrated expertise in the relevant areas.

Original research papers contain innovative, hypothesis-driven research that is supported by sound experimental design, methodology, and data interpretation.

Brief technical notes, normally more limited in scope than original research papers, must be of high quality, general interest, and sufficient importance to warrant publication.

Rapid communications provide a venue for fast-breaking research updates or other news items.

The justification for rapid communication should be stated in the cover letter during submission.

Regulatory notes provide a summary of regulatory decisions made and rationale for the regulatory decision made on a product. These notes are typically submitted by invitation only, but authors may propose notes to the editors.

Editorials, commentaries, or summaries are usually published by invitation only. These articles contain topical issues of public and scientific interest.

Meeting reports on AAPS or AAPS-affiliated meetings provide readers with summaries of such meetings, including consensus views. When a meeting report purports to be a consensus report, it may, at the editor-in-chief’s discretion, adhere to the AAPS Guideline for Review of Opinions and Summary Reports, available at www.aaps.org/guidelineopinions. The corresponding author must complete and submit the Corresponding Author’s Consent to Publish form (www.aaps.org/consentcorr) and all contributing authors must complete and submit the Contributing Author’s Consent to Publish form (www.aaps.org/consentcont).

Meeting notices provide readers with information on upcoming AAPS or AAPS-affiliated meetings.

They should include the title of the meeting, date, time, location, an outline, description of meeting topics, and a list of invited speakers. If possible, meeting notices should include contact information for the organizers and a URL to the meeting’s webpage. Meeting notices should be submitted to the AAPS Editorial Office 2–3 months prior to the meeting.

Letters to the editor may be submitted by readers commenting on articles already published by the journal.

White Papers describe a current problem or issue and propose a solution. White papers written on behalf of AAPS groups are subject to the AAPS Guideline for Review of Opinions and Summary Reports (www.aaps.org/guidelineopinions) at the discretion of the editor-in-chief.

All articles published in the journal will follow the Springer Online First production workflow, enabling publication on the SpringerLink website after receipt of author corrections to page proofs.

MANUSCRIPT SUBMISSION

AAPS uses Editorial Manager as its peer review tracking system. Manuscripts must be submitted online by the corresponding author at www.editorialmanager.com/aapspt. You may be required to register as a new user with Editorial Manager upon your first visit. Straightforward sign in and registration procedures can be found on the website. Editorial Manager allows authors to track the progress of manuscript review in real time. Detailed, step-by-step instructions for submitting manuscripts can be found on the website. All correspondence regarding your manuscript must go through Editorial Manager.

SPECIAL FEATURES, APPENDICES, AND SUPPLEMENTARY MATERIAL

These materials can be accommodated and may contain highly interactive features or large databases. All authors are encouraged to take full advantage of the Web-only capabilities of online publishing, including 3-D, video, and interactive graphics. All special features must be created by the author.

Authors who wish to publish electronic supplementary material with their article (Excel files, images, audio/video files, etc.) must submit the supplementary files/materials with their manuscript submission via our online peer review tracking system, Editorial Manager. These files may be submitted as one file or multiple files as desired by the authors. Accepted formats for these files include DOC, DOCX, XLS, XLSX, JPG, PDF, and for videos, MPEG-3 format. If a desired technical feature is in a different format or not covered in the author instructions, please contact the AAPS Editorial Office (AAPSPT@aaps.org) for assistance. Note that supplementary files are not automatically sent to production if the article is accepted. Please therefore note in a cover letter if these materials should be evaluated by reviewers only (not published), or if the supplemental files should be included for review and be published with the article should the manuscript be accepted for publication. If the supplemental files are intended for publication, references using 3

supplemental 1,” “supplemental 2,” etc. should be placed in the appropriate location within the text of the manuscript body. Supplemental files are published as-is, with no copyediting or formatting by Production.

 

主编辑:

 

德克萨斯大学奥斯汀分校罗伯特·威廉姆斯(Robert O. Williams),美国得克萨斯州奥斯汀分校

 

编辑:

 

Sanyog Jain,印度旁遮普邦制药教育与研究国家制药系;

 

美国亚利桑那州图森市药学学院亚利桑那大学保罗·梅德尔达(Paul Myrdal

 

迈克尔·Repka,密西西比大学,药学院,牛津,密西西比州美国;

 

罗萨里奥国立大学Claudio Salomon,阿根廷罗萨里奥药剂部;

 

丘宾·Wu,中山大学大学药物科学,广东省,中国的学校;

 

 

编辑顾问委员会:

 

爱尔兰贝尔法斯特皇后大学药学院Gavin Andrews ;

 

伦敦大学学院伦敦药学院的Abdul Bassit ;

 

康涅狄格大学药物科学系Robin Bogner,美国康涅狄格州Storrs

 

弗朗塞斯卡·巴尼,药房,帕尔马,意大利帕尔马大学的系;

 

美国印第安纳州西拉斐特,普渡大学Stephen R. Byrn ;

 

意大利帕维亚帕维亚大学Carla Caramella ;

 

夏威夷大学药学院Mahavir B. Chougule,美国夏威夷希洛,

 

东京医科牙科大学,日本东京Masato Yasuhara

 

费拉拉大学费拉拉大学药学院盖亚科伦坡,意大利

 

意大利帕尔马帕尔马大学保罗科伦坡保罗

 

Tansel Comoglu,安卡拉大学药,安卡拉,土耳其的教师;

 

美国威斯康辛州麦迪逊威斯康星大学的Melgardt M. De Villiers ;

 

美国新泽西州Kenilworth MerckCo.Inc.James C. DiNunzio ;

 

美国新墨西哥州新墨西哥大学药学系Linda Felton ;

 

新加坡国立大学药学系Paul Heng,新加坡;

 

北卡罗来纳大学,美国北卡罗来纳州Chapel HillAnthony J. Hickey ; 美国马里兰州银泉市食品药物管理局的

 

Mansoor Khan

 

德国杜塞尔多夫 Heinrich Heine大学的Peter Kleinebudde ;

 

德国波恩药剂学博士,波恩大学,阿尔夫·兰德雷赫特 ;

 

美国马里兰州Silver Spring生物等效性食品和药物管理司Prashanth Manda ;

 

美国新泽西州Nutley Hoffmann-La Roche制药和分析研究与开发部的Dave A. Miller ;

 

智利智利大学化学与药物科学学院Javier Morales ;

 

密西西比州密西西比大学药学院Narasimha Murthy,密西西比州美国;

 

沃斯菲·奥贝达特,科技,约旦约旦大学;

 

韩国首尔Sungkyunkwan大学Eun-Seok公园 ;

 

Viness Pillay,南非约翰内斯堡Witwatersrand大学药学与药理学系;

 

Stuart Porter,亚什兰特种成分(ASI),ParlinNew JerseyUSA;

 

哥本哈根哥本哈根大学药学系Thomas Rades,哥本哈根;

 

美国奥本阿拉巴马州奥本大学哈里森药学院的Jay Babu Ramapuram ;

 

意大利帕尔马帕尔马大学药学院的Alessandra Rossi ;

 

法国里尔法国里尔大学Juergen Siepmann ;

 

Socrates Tabosa do EgitoDepartamento de FarmaciaUniversidade Federal do do Rio Grande do NorteBrazil;

 

韦·Wu,药房,上海,中国的复旦大学医学院;

 

澳大利亚悉尼澳大利亚悉尼悉尼悉尼医学院保罗·杨(Paul Young


投稿问答最小化  关闭